Compound Information | SONAR Target prediction | Name: | MYRICETIN | Unique Identifier: | SPE01504065 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C15H10O8 | Molecular Weight: | 308.156 g/mol | X log p: | 9.93000000000001 (online calculus) | Lipinksi Failures | 1 | TPSA | 26.3 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 8 | Rotatable Bond Count: | 1 | Canonical Smiles: | Oc1cc(O)c2C(=O)C(O)=C(Oc2c1)c1cc(O)c(O)c(O)c1 | Source: | ex Myrica spp | Reference: | J Chem Soc 81: 203 (1902); PNAS 97: 4790 (2000) | Therapeutics: | antiHIV, topoisomerase II inhibitor | Generic_name: | 2-(3,4,5-TRIHYDROXYPHENYL)-3,5,7-TRIHYDR | Chemical_iupac_name: | 3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE | Drug_type: | Experimental | Drugbank_id: | EXPT02265 | Drug_category: | Phosphatidylinositol 3-Kinase Catalytic Subu inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
YPT6 |
Replicates: |
2 |
Raw OD Value: r im |
0.7148±0.0108187 |
Normalized OD Score: sc h |
1.0043±0.00764097 |
Z-Score: |
0.1384±0.249718 |
p-Value: |
0.861164 |
Z-Factor: |
-9.48671 |
Fitness Defect: |
0.1495 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 10|B7 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 22.40 Celcius | Date: | 2006-02-22 YYYY-MM-DD | Plate CH Control (+): | 0.040775000000000006±0.00103 | Plate DMSO Control (-): | 0.68765±0.01434 | Plate Z-Factor: | 0.9423 |
| png ps pdf |
DBLink | Rows returned: 3 | |
5280343 |
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one |
5281672 |
3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one |
5284452 |
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one dihydrate |
internal high similarity DBLink | Rows returned: 12 | << Back 1 2 |
active | Cluster 10732 | Additional Members: 22 | Rows returned: 8 | 1 2 Next >> |
|